Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

768 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Two cases of dupilumab-responsive Kimura disease.
Battesti G, Jachiet M, Lepelletier C, Petit A, Vignon-Pennamen MD, Cassius C, de Masson A, Battistella M, Bagot M, Bouaziz JD, Mahévas T. Battesti G, et al. Among authors: bagot m. Clin Exp Dermatol. 2024 Apr 23;49(5):502-506. doi: 10.1093/ced/llad455. Clin Exp Dermatol. 2024. PMID: 38149974
CD39 is expressed by a wide range of cutaneous T-cell lymphomas.
Battesti G, Thonnart N, Bozonnat A, Ram-Wolff C, de Masson A, Bensussan A, Bagot M, Marie-Cardine A, Battistella M. Battesti G, et al. Among authors: bagot m. Skin Health Dis. 2024 Jan 10;4(2):e334. doi: 10.1002/ski2.334. eCollection 2024 Apr. Skin Health Dis. 2024. PMID: 38577051 Free PMC article.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Free article. Clinical Trial.
Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project.
Roccuzzo G, Calvão J, Dobos G, Morsia E, Mozas P, Peterknecht E, Schrader AMR, Zottarelli F, Bagot M, Stadler R, Vermeer M, Quaglino P, Scarisbrick J. Roccuzzo G, et al. Among authors: bagot m. Br J Dermatol. 2024 Apr 5:ljae145. doi: 10.1093/bjd/ljae145. Online ahead of print. Br J Dermatol. 2024. PMID: 38576352 No abstract available.
Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sézary syndrome using Time to Next Treatment as a measure of clinical benefit: An EORTC CLTG study.
Mitsunaga K, Bagot M, Ram-Wolff C, Guenova E, von Gugelberg C, Hodak E, Amitay-Laish I, Papadavid E, Jonak C, Porkert S, Scarisbrick J, Applewaite R, Beylot-Barry M, Nicolay J, Quaglino P, Sanches JA, Cury-Martins J, Lora-Pablos D, Ortiz P. Mitsunaga K, et al. Among authors: bagot m. Br J Dermatol. 2024 Apr 10:ljae152. doi: 10.1093/bjd/ljae152. Online ahead of print. Br J Dermatol. 2024. PMID: 38596857
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M; ALCANZA study group. Prince HM, et al. Lancet. 2017 Aug 5;390(10094):555-566. doi: 10.1016/S0140-6736(17)31266-7. Epub 2017 Jun 7. Lancet. 2017. PMID: 28600132
Effectiveness and safety of mogamulizumab for the treatment of Sézary syndrome in very elderly patients: A real-world, multicentre, retrospective study conducted in France.
Ribereau-Gayon E, Beylot-Barry M, De Masson A, Ram-Wolff C, Bagot M, Pham-Ledard A, Grange F. Ribereau-Gayon E, et al. Among authors: bagot m. J Eur Acad Dermatol Venereol. 2024 May 28. doi: 10.1111/jdv.20127. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38804019 No abstract available.
768 results